Single-Cell Profiling Identifies Aberrant STAT5 Activation in Myeloid Malignancies with Specific Clinical and Biologic Correlates
- 1 October 2008
- journal article
- research article
- Published by Elsevier in Cancer Cell
- Vol. 14 (4), 335-343
- https://doi.org/10.1016/j.ccr.2008.08.014
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Development of an allele-specific minimal residual disease assay for patients with juvenile myelomonocytic leukemiaBlood, 2008
- Genotype-phenotype correlation in cases of juvenile myelomonocytic leukemia with clonal RAS mutationsBlood, 2008
- Hematopoietic cytokine receptor signalingOncogene, 2007
- Spontaneous improvement of hematologic abnormalities in patients having juvenile myelomonocytic leukemia with specific RAS mutationsBlood, 2007
- Myeloproliferative disease induced by TEL-PDGFRB displays dynamic range sensitivity to Stat5 gene dosageBlood, 2007
- K-RasG12D expression induces hyperproliferation and aberrant signaling in primary hematopoietic stem/progenitor cellsBlood, 2006
- β common receptor inactivation attenuates myeloproliferative disease in Nf1 mutant miceBlood, 2006
- Germline KRAS mutations cause Noonan syndromeNature Genetics, 2006
- Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorderBlood, 2004
- P210 and P190 Induce the Tyrosine Phosphorylation and DNA Binding Activity of Multiple Specific STAT Family MembersJournal of Biological Chemistry, 1996